Luty Jason, Nikolaou Vasilis, Bearn Jenny
Marina House, Addictions Resource Centre, 63/65 Denmark Hill, SE5 8RS, Camberwell, London, UK.
J Subst Abuse Treat. 2003 Jun;24(4):363-7. doi: 10.1016/s0740-5472(03)00035-7.
Despite the widespread avoidance of detoxification in the second or third trimesters, there is no clear evidence to support the view that methadone withdrawal is harmful in pregnant opiate dependent women. We investigated the safety of methadone detoxification in pregnancy in a retrospective case series of 101 pregnant opiate dependent women who underwent a 21-day in-patient methadone withdrawal. One miscarriage occurred in the first trimester (n = 5; incidence rate ratio of 6.87 compared to population norms (95% CI = 0.16-47.3; p =.15)). No miscarriages were observed in the second trimester (n = 54; incidence rate ratio = 0 compared to population norms (95% CI = 0-3.69; p =.27). One premature delivery occurred in the third trimester (1 in 158 weeks at risk compared to 1 in 150 weeks in population norms; p =.16). Methadone detoxification treatment was not associated with any increased risk of miscarriage in the second trimester or premature delivery in the third trimester.
尽管在妊娠中期或晚期普遍避免进行戒毒,但尚无明确证据支持美沙酮戒断对依赖阿片类药物的孕妇有害这一观点。我们对101名接受了为期21天住院美沙酮戒断治疗的依赖阿片类药物的孕妇进行了回顾性病例系列研究,以调查孕期美沙酮戒毒的安全性。孕早期发生了1例流产(n = 5;与总体标准相比,发病率比为6.87(95%置信区间 = 0.16 - 47.3;p = 0.15))。孕中期未观察到流产(n = 54;与总体标准相比,发病率比 = 0(95%置信区间 = 0 - 3.69;p = 0.27))。孕晚期发生了1例早产(处于风险中的158周中有1例,而总体标准为150周中有1例;p = 0.16)。美沙酮戒毒治疗与孕中期流产风险增加或孕晚期早产风险增加均无关。